ATG9A-EGFP
(Plasmid
#210367)
-
PurposeExpresses ATG9A fused with EGFP in mammalian cells
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 210367 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepEGFP-N1
- Backbone size w/o insert (bp) 4700
- Total vector size (bp) 7296
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameATG9A
-
SpeciesH. sapiens (human)
-
Insert Size (bp)2517
-
GenBank IDNM_024085.5
-
Entrez GeneATG9A (a.k.a. APG9L1, MGD3208, mATG9)
-
Tag
/ Fusion Protein
- EGFP (C terminal on insert)
Cloning Information
- Cloning method Ligation Independent Cloning
- 5′ sequencing primer CMV-F
- 3′ sequencing primer EGFP (Cterm) (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made bySino Biological HG22214-U
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
ATG9A-EGFP was a gift from Michele Pagano (Addgene plasmid # 210367 ; http://n2t.net/addgene:210367 ; RRID:Addgene_210367) -
For your References section:
The REEP5/TRAM1 complex binds SARS-CoV-2 NSP3 and promotes virus replication. Li J, Gui Q, Liang FX, Sall J, Zhang Q, Duan Y, Dhabaria A, Askenazi M, Ueberheide B, Stapleford KA, Pagano M. J Virol. 2023 Sep 28:e0050723. doi: 10.1128/jvi.00507-23. 10.1128/jvi.00507-23 PubMed 37768083